Bridgeway Capital Management’s Zevra Therapeutics ZVRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-95,143	Closed	-$660K	–	1305
2024 Q3	$660K	Hold	95,143	–	–	0.01%	791
2024 Q2	$466K	Hold	95,143	–	–	0.01%	874
2024 Q1	$552K	Hold	95,143	–	–	0.01%	897
2023 Q4	$623K	Hold	95,143	–	–	0.01%	888
2023 Q3	$459K	Hold	95,143	–	–	0.01%	904
2023 Q2	$485K	Hold	95,143	–	–	0.01%	912
2023 Q1	$523K	Buy	95,143 +5,700	+6%	+$30.2K	0.01%	875
2022 Q4	$411K	Buy	89,443 +20,500	+30%	+$104K	0.01%	930
2022 Q3	$430K	Hold	68,943	–	–	0.01%	927
2022 Q2	$307K	Buy	+68,943	New	+$314K	0.01%	991
2019 Q4	–	Sell	-8,138	Closed	-$90K	–	1395
2019 Q3	$90K	Hold	8,138	–	–	﹤0.01%	1251
2019 Q2	$228K	Hold	8,138	–	–	﹤0.01%	1157
2019 Q1	$217K	Buy	8,138 +4,700	+137%	+$173K	﹤0.01%	1212
2018 Q4	$98K	Hold	3,438	–	–	﹤0.01%	1307
2018 Q3	$264K	Buy	+3,438	New	+$269K	﹤0.01%	1277